Skip to main content
$1.02 -$0.04 (-3.8%)

04:00 PM EDT on 09/20/21

Celsion Corp (NASDAQ:CLSN)

CAPS Rating: No stars

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.

Current Price $1.02 Mkt Cap $91.8M
Open $1.01 P/E Ratio 0.00
Prev. Close $1.02 Div. (Yield) $0.00 (0.0%)
Daily Range $0.98 - $1.04 Volume 1,741,772
52-Wk Range $0.43 - $3.48 Avg. Daily Vol. 1,128,254

Caps

How do you think NASDAQ:CLSN will perform against the market?

Add Stock to CAPS Watchlist

All Players

76 Outperform
15 Underperform
 

All-Star Players

4 Outperform
4 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CLSN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Kdhard1 (< 20)
Submitted May 04, 2012

Let me start by saying this is a speculative play. Celsion currently is in Phase III of their clinical trial for treatment for liver cancer and Phase II for breast cancer. The stock has pulled well back from its highs but has held stable at its… More

zzlangerhans (99.06)
Submitted June 04, 2016

I just updated my Celsion database and I was surprised to see the company with a positive enterprise value. They had 14M cash and 6M debt as of the end of March, and they burn around 6M per quarter. They'll run out of cash around October if they… More

NASDAQ:CLSN VS S&P 500 (SPY)

Fools bullish on NASDAQ:CLSN are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about CLSN.

Recs

0
Member Avatar Bashar (< 20) Submitted: 4/16/2021 12:01:43 PM : Outperform Start Price: $1.51 NASDAQ:CLSN Score: -34.72

Their great results will appear soon

Recs

0
Member Avatar salamander1 (73.05) Submitted: 2/22/2021 3:12:37 PM : Outperform Start Price: $3.05 NASDAQ:CLSN Score: -78.11

The company received Food and Drug Administration Fast Track status for a Phase 2 treatment for advanced ovarian cancer.

Recs

0
Member Avatar DaytradingStars (55.83) Submitted: 6/20/2020 11:48:59 PM : Outperform Start Price: $5.19 NASDAQ:CLSN Score: -121.30

Q4.5 WS4.5 MOMOA- EPS-A

Leaderboard

Find the members with the highest scoring picks in CLSN.

Score Leader

zzlangerhans

zzlangerhans (99.06) Score: +475.20

The Score Leader is the player with the highest score across all their picks in CLSN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
stratisticalarb < 20 6/9/2011 Underperform 1Y $200.34 -99.49% +237.10% +336.59 0 Comment
pascella < 20 6/26/2012 Underperform 3Y $199.71 -99.49% +229.60% +329.09 0 Comment
BlacknGold2 20.47 7/5/2012 Underperform 5Y $229.32 -99.56% +217.08% +316.63 0 Comment
MFBurritoSquat 71.80 11/28/2012 Underperform 3M $462.82 -99.78% +211.03% +310.81 0 Comment
TimeToBuy 90.22 12/18/2012 Underperform 5Y $488.88 -99.79% +201.44% +301.24 0 Comment
Imhilion 36.82 1/2/2013 Underperform 5Y $525.42 -99.81% +199.14% +298.94 1 Comment
4dead 20.59 4/1/2013 Underperform 5Y $64.26 -98.41% +177.21% +275.62 0 Comment
KidJones 97.61 5/24/2013 Underperform 5Y $62.37 -98.36% +163.93% +262.29 0 Comment
cavemantrader 70.63 12/19/2013 Underperform 5Y $52.36 -98.05% +139.57% +237.62 0 Comment
Moondoggie 98.12 12/4/2014 Underperform 5Y $33.60 -96.96% +108.95% +205.92 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CLSN.